'Mad Money' Uncover...
Health Care: Drugs
Questcor Pharmaceuticals Inc. (QCOR: NASDAQ)
$37.21 -0.40 | -1.06%
05/21/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 37.61 |
| 52 Week High | 58.91 |
| 52 Week Low | 17.25 |
| Avg. Daily Vol. (Mil) | 2.02 |
| Beta (3 year) | 0.83 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,239.83 |
| Shares Out (Mil) | 59.55 |
| Float (Mil) | 45.64 |
| Dividend Information | |
| Yield % | 2.70 |
| Annual Dividend | 1.00 |
| Payout Ratio | 12.00 |
| Financial Strength | |
| Quick Ratio | 2.30 |
| Current Ratio | 2.60 |
| LT Debt/ Equity | 0.08 |
| Total Debt / Equity | 0.09 |
| Valuation Ratios | |
| Price Earnings | 11.60 |
| Price/Sales | 4.08 |
| Price/Book | 11.45 |
| Price/Cash Flow | 11.10 |
| Per Share Data | |
| Earnings | 3.23 |
| Sales | 9.21 |
| Book Value | 3.29 |
| Cash Flow | 3.40 |
| Business Summary | |
|---|---|
| Questcor Pharmaceuticals Inc is a biopharmaceutical company, that provides prescription drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. | |
| General Information | |
| 1300 North Kellogg Drive
Suite D Anaheim, CA 92807 |
|
| www.questcor.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 557 | |
| CEO: Don M. Bailey | |
| Short Interest | |
| Current Month (Mil) | 27.15 |
| Previous Month (Mil) | 27.32 |
| Short Interest Ratio (Days) | 17.20 |
| Management Effectiveness | |
| Return on Equity | 101.00 |
| Return on Assets | 57.30 |
| Return on Investments | 93.60 |
| Profitability | |
| Gross Margin | 93.20 |
| EBIT Margin | 54.30 |
| Profit Margin | 36.10 |
Portfolios with QCOR
- Portfolio NameUser Type
- User5
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- UserCoreFolio
- ProChase Coleman - Tiger Globa...
- ContributorStocks With Big Insider Buy...
- UserD-ZYRE
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
Latest QCOR Headlines from TheStreet
- Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Laggard 05.21.13 | 05:05 pm
- Questcor Rises On Unusually High Volume (QCOR) 05.14.13 | 04:05 pm
- Questcor Rises On Unusually High Volume (QCOR) 05.01.13 | 04:05 pm
- Earnings Parade Continues Next Week
04.26.13 | 02:04 pm - Questcor Pharmaceuticals Stock Sees Short Interest Make 12.8% Move 04.25.13 | 03:04 pm
- Questcor Stock To Go Ex-dividend Tomorrow (QCOR) 04.17.13 | 10:04 am
- DMLP, CBD, QCOR 04.17.13 | 10:04 am
- Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Straggler 04.08.13 | 05:04 pm
- 4 Stocks Undervalued By To Target Price With Short Covering 04.05.13 | 12:04 pm
- Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner 03.18.13 | 05:03 pm
Press Releases for QCOR
- Questcor Pharmaceuticals To Present At Bank Of America Merrill Lynch 2013 Healthcare Conference - PR Newswire 05.08.13 | 04:05 pm
- Questcor To Report First Quarter Results On April 30, 2013 - PR Newswire 04.15.13 | 06:04 am
- Shareholder Rights Law Firm Johnson & Weaver, LLP Is Appointed By The United States District Court To Pursue Claims For The Benefit Of Questcor And Its Shareholders - Business Wire 02.14.13 | 07:02 am
- Questcor To Report Fourth Quarter And Full Year 2012 Financial Results On February 26, 2013 - PR Newswire 02.06.13 | 04:02 pm
- Questcor Pharmaceuticals Appoints Michael Aldridge To The Position Of Senior Vice President, Corporate Strategic Development - PR Newswire 01.28.13 | 06:01 am
- Questcor Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - PR Newswire 01.03.13 | 06:01 am
- Questcor Pharmaceuticals To Acquire BioVectra Inc. - PR Newswire 01.02.13 | 04:01 pm
- Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set For December 21, 2012 - PR Newswire 12.04.12 | 07:12 am
- Questcor And Child Neurology Foundation Support The 4th Annual Infantile Spasms Awareness Week - PR Newswire 12.03.12 | 07:12 am
- Questcor Teams With Child Neurology Foundation To Continue Funding Infantile Spasms Scientific Research - PR Newswire 12.03.12 | 06:12 am
Partner Headlines for QCOR
- Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013 - NASDAQ 04.17.13 | 01:04 pm
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- AbbVie Offers Nice Dividend Yield, Stock At New High - Investor's Business Daily 04.01.13 | 05:04 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Solid Where It Matters: Questcor To Climb On Strong Quarter And Dividend Raise - Seeking Alpha 02.27.13 | 09:02 am
- Stocks Defend Early Gains; SunPower, First Solar White Hot - Investor's Business Daily 02.19.13 | 12:02 pm
- What Makes For A Market Leading Return In Biotechnology? - Seeking Alpha 01.22.13 | 09:01 am
- Tiger Global's Most Promising Stock Picks - Seeking Alpha 01.11.13 | 09:01 am
- Mid-Day Market Update: Herbalife Rallies While Quicksilver Resources Drops - Benzinga 12.28.12 | 01:12 pm
- Questcor Pharmaceuticals Dip Offers Opportunity In Front Of Acthar Script Data - Seeking Alpha 12.03.12 | 09:12 am
